Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Breast Cancer

Free Subscription Articles published in Anticancer Res Retrieve available abstracts of 112 articles: HTML format Text format

Single Articles

February 2012
1. 
   Targeted therapies in breast cancer.
   Anticancer Res. 2012;32:719.
   PubMed     Text format     Related articles   
   
   
   
   
2. WAZIR U , Jiang WG, Sharma AK, Mokbel K, et al
   The mRNA Expression of DAP3 in Human Breast Cancer: Correlation with Clinicopathological Parameters.
   Anticancer Res. 2012;32:671-4.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. LIN CY , Ho CM, Bau DT, Yang SF, et al
   Evaluation of Breast Cancer Susceptibility Loci on 2q35, 3p24, 17q23 and FGFR2 Genes in Taiwanese Women with Breast Cancer.
   Anticancer Res. 2012;32:475-482.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   January 2012
4. SERGEEV IN
   Vitamin d and cellular Ca2+ signaling in breast cancer.
   Anticancer Res. 2012;32:299-302.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. LOPES N , Carvalho J, Duraes C, Sousa B, et al
   1Alpha,25-dihydroxyvitamin D3 Induces de novo E-cadherin Expression in Triple-negative Breast Cancer Cells by CDH1-promoter Demethylation.
   Anticancer Res. 2012;32:249-57.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. PACINI S , Punzi T, Morucci G, Gulisano M, et al
   Effects of Vitamin D-binding Protein-derived Macrophage-activating Factor on Human Breast Cancer Cells.
   Anticancer Res. 2012;32:45-52.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. EINBOND LS , Soffritti M, Esposti DD, Tibaldi E, et al
   Chemopreventive potential of black cohosh on breast cancer in sprague-dawley rats.
   Anticancer Res. 2012;32:21-30.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. NAWA M , Osada S, Morimitsu K, Nonaka K, et al
   Growth Effect of Neutrophil Elastase on Breast Cancer: Favorable Action of Sivelestat and Application to Anti-HER2 Therapy.
   Anticancer Res. 2012;32:13-9.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   December 2011
9. TAKEUCHI H , Hiroshige S, Hashimoto K, Kusumoto T, et al
   Synchronous double tumor of breast cancer and gastrointestinal stromal tumor in a patient with neurofibromatosis type 1: report of a case.
   Anticancer Res. 2011;31:4481-4.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. MIRCHANDANI D , Roses DF, Inghirami G, Zeleniuch-Jacquotte A, et al
    Loss of p27KIP1 Expression in Fully-staged Node-negative Breast Cancer: Association with Lack of Hormone Receptors in T1a/b, but not T1c Infiltrative Ductal Carcinoma.
    Anticancer Res. 2011;31:4401-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. HOELLEN F , Kelling K, Dittmer C, Diedrich K, et al
    Impact of cyclooxygenase-2 in breast cancer.
    Anticancer Res. 2011;31:4359-67.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. LEE KY , Kim YJ, Yoo H, Lee SH, et al
    Human Brain Endothelial Cell-derived COX-2 Facilitates Extravasation of Breast Cancer Cells Across the Blood-brain Barrier.
    Anticancer Res. 2011;31:4307-13.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. CAI FF , Kohler C, Zhang B, Chen WJ, et al
    Mutations of mitochondrial DNA as potential biomarkers in breast cancer.
    Anticancer Res. 2011;31:4267-71.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. PATANI N , Jiang WG, Newbold RF, Mokbel K, et al
    Histone-modifier Gene Expression Profiles Are Associated with Pathological and Clinical Outcomes in Human Breast Cancer.
    Anticancer Res. 2011;31:4115-25.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. SINGH NP , Lai HC, Park JS, Gerhardt TE, et al
    Effects of artemisinin dimers on rat breast cancer cells in vitro and in vivo.
    Anticancer Res. 2011;31:4111-4.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. MIKALSEN LT , Dhakal HP, Bruland OS, Nesland JM, et al
    Quantification of Angiogenesis in Breast Cancer by Automated Vessel Identification in CD34 Immunohistochemical Sections.
    Anticancer Res. 2011;31:4053-60.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2011
17. WARM M , Duda V, Eichler C, Harbeck N, et al
    3D Breast Ultrasound: A Significant Predictor in Breast Cancer Reduction under Pre-operative Chemotherapy.
    Anticancer Res. 2011;31:4039-42.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. KOPP HG , Krauss K, Fehm T, Staebler A, et al
    Symptomatic bone marrow involvement in breast cancer - clinical presentation, treatment, and prognosis: a single institution review of 22 cases.
    Anticancer Res. 2011;31:4025-30.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. ESKELINEN M , Ollonen P
    Measurement of pessimism: hopelessness scale in healthy study subjects, and in patients with benign breast disease and breast cancer: a prospective case-control study in Finland.
    Anticancer Res. 2011;31:4019-23.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. ESKELINEN M , Ollonen P
    Assessment of 'Cancer-prone Personality' Characteristics in Healthy Study Subjects and in Patients with Breast Disease and Breast Cancer Using the Commitment Questionnaire: A Prospective Case-Control Study in Finland.
    Anticancer Res. 2011;31:4013-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. HIRANO T , Hirose K, Sakurai K, Makishima M, et al
    Inhibition of Tumor Growth by Antibody to ADAMTS1 in Mouse Xenografts of Breast Cancer.
    Anticancer Res. 2011;31:3839-42.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. KIM S , Han J, Kim JS, Kim JH, et al
    Silibinin Suppresses EGFR Ligand-induced CD44 Expression through Inhibition of EGFR Activity in Breast Cancer Cells.
    Anticancer Res. 2011;31:3767-73.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2011
23. 
    Breast cancer, a heterogeneous disease entity. The very early stages.
    Anticancer Res. 2011;31:3641-2.
    PubMed     Text format     Related articles   
    
    
    
    
24. CHOU SE , Huang CY, Sheen-Chen SM, Liu YW, et al
    An Evaluation of Prognostic Value of Death-associated Protein Kinase 1 in Breast Cancer.
    Anticancer Res. 2011;31:3633-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. HOFFMANN O , Aktas B, Goldnau C, Heubner M, et al
    Effect of ibandronate on disseminated tumor cells in the bone marrow of patients with primary breast cancer: a pilot study.
    Anticancer Res. 2011;31:3623-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. YAMAMOTO D , Iwase S, Yoshida H, Kuroda Y, et al
    Efficacy of Meloxicam in Combination with Preoperative Chemotherapy for Breast Cancer - Japan Breast Cancer Research Network (JBCRN) 02-1 Trial.
    Anticancer Res. 2011;31:3567-71.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. YAMAMOTO D , Tsubota Y, Yoshida H, Kanematsu S, et al
    Endoscopic appearance and clinicopathological character of breast cancer.
    Anticancer Res. 2011;31:3517-20.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. LIU LC , Su CH, Wang HC, Tsai CW, et al
    Significant Association of Caveolin-1 (CAV1) Genotypes with Breast Cancer in Taiwan.
    Anticancer Res. 2011;31:3511-3515.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. GUTWEIN LG , Al-Quran SZ, Fernando S, Fletcher BS, et al
    Tumor Endothelial Marker 8 Expression in Triple-negative Breast Cancer.
    Anticancer Res. 2011;31:3417-22.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. SEO HS , Choi HS, Choi HS, Choi YK, et al
    Phytoestrogens Induce Apoptosis via Extrinsic Pathway, Inhibiting Nuclear Factor-{kappa}B Signaling in HER2-overexpressing Breast Cancer Cells.
    Anticancer Res. 2011;31:3301-13.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. EICHBAUM C , Meyer AS, Wang N, Bischofs E, et al
    Breast Cancer Cell-derived Cytokines, Macrophages and Cell Adhesion: Implications for Metastasis.
    Anticancer Res. 2011;31:3219-27.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. PAZDIORA P , Svobodova S, Fuchsova R, Kucera R, et al
    Vitamin d in colorectal, breast, prostate and lung cancer: a pilot study.
    Anticancer Res. 2011;31:3619-21.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. QAMAR S , Carrasquer CA, Cunningham SL, Cunningham AR, et al
    Anticancer SAR models for MCF-7 and MDA-MB-231 breast cell lines.
    Anticancer Res. 2011;31:3247-52.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
34. ESKELINEN M , Ollonen P
    Sifneos alexithymia questionnaire in assessment of general alexithymia in patients with breast disease and breast cancer: a prospective case-control study in Finland.
    Anticancer Res. 2011;31:3101-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. TALIERI M , Devetzi M, Scorilas A, Prezas P, et al
    Evaluation of Kallikrein-related Peptidase 5 Expression and its Significance for Breast Cancer Patients: Association with Kallikrein-related Peptidase 7 Expression.
    Anticancer Res. 2011;31:3093-100.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. HORIGUCHI J , Oyama T, Takata D, Rokutanda N, et al
    Pathological Complete Response and Prognosis in Patients Receiving Neoadjuvant Paclitaxel and Trastuzumab with and without Anthracyclines for Stage II and III, HER2-positive Operable Breast Cancer: A Single-institute Experience.
    Anticancer Res. 2011;31:3041-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. NAKAYAMA T , Morita S, Takashima T, Kamigaki S, et al
    Phase I Study of S-1 in Combination with Trastuzumab for HER2-positive Metastatic Breast Cancer.
    Anticancer Res. 2011;31:3035-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. FOUNTZILAS G , Kourea HP, Bobos M, Televantou D, et al
    Paclitaxel and bevacizumab as first line combined treatment in patients with metastatic breast cancer: the hellenic cooperative oncology group experience with biological marker evaluation.
    Anticancer Res. 2011;31:3007-18.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. BUHMEIDA A , Merdad A, El-Maghrabi J, Al-Thobaiti F, et al
    RASSF1A Methylation is Predictive of Poor Prognosis in Female Breast Cancer in a Background of Overall Low Methylation Frequency.
    Anticancer Res. 2011;31:2975-81.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. MOHR SB , Gorham ED, Alcaraz JE, Kane CJ, et al
    Serum 25-hydroxyvitamin d and prevention of breast cancer: pooled analysis.
    Anticancer Res. 2011;31:2939-48.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. JIANG XP , Yang DC, Elliott RL, Head JF, et al
    Down-regulation of Expression of Interleukin-6 and its Receptor Results in Growth Inhibition of MCF-7 Breast Cancer Cells.
    Anticancer Res. 2011;31:2899-906.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. SCHINDLBECK C , Pfab G, Jueckstock J, Andergassen U, et al
    Prognostic relevance of disseminated tumor cells in the bone marrow of patients with primary breast cancer - results of a standardized follow-up.
    Anticancer Res. 2011;31:2749-55.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. LIU H , Zang C, Schefe JH, Schwarzlose-Schwarck S, et al
    The mTOR Inhibitor RAD001 Sensitizes Tumor Cells to the Cytotoxic Effect of Carboplatin in Breast Cancer In Vitro.
    Anticancer Res. 2011;31:2713-22.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. CARUSO R , Palmeri R, Racchiusa S, Bonanno A, et al
    Pleomorphic ductal carcinoma of the male breast: report of a rare case and review of literature.
    Anticancer Res. 2011;31:3069-71.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
45. WOJNAR A , Pula B, Piotrowska A, Jethon A, et al
    Correlation of intensity of MT-I/II expression with Ki-67 and MCM-2 proteins in invasive ductal breast carcinoma.
    Anticancer Res. 2011;31:3027-33.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. PEREZ J , Bardin C, Rigal C, Anthony B, et al
    Anti-MDR1 siRNA restores chemosensitivity in chemoresistant breast carcinoma and osteosarcoma cell lines.
    Anticancer Res. 2011;31:2813-20.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
47. ZHENG J , Benbrook DM, Yu H, Ding WQ, et al
    Clioquinol suppresses cyclin D1 gene expression through transcriptional and post-transcriptional mechanisms.
    Anticancer Res. 2011;31:2739-47.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
48. SCHROEDER JK , Kuemmel S, Pietzner K, Hector J, et al
    Optimizing the Clinical Management of Gynecological and Breast Cancer via Online Tumor Conferences.
    Anticancer Res. 2011;31:2669-73.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
49. EGGEMAN H , Stoblen F, Thill M, Korlach S, et al
    Influence of a Dose-dense Adjuvant Chemotherapy on sVCAM-1/sICAM-1 Serum Levels in Breast Cancer Patients with 1-3 Positive Lymph Nodes.
    Anticancer Res. 2011;31:2617-22.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
50. STOBLEN F , Landt S, Ishaq R, Stelkens-Gebhardt R, et al
    High-frequency Breast Ultrasound for the Detection of Microcalcifications and Associated Masses in BI-RADS 4a Patients.
    Anticancer Res. 2011;31:2575-81.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
51. STOBLEN F , Landt S, Stelkens-Gebhardt R, Sehouli J, et al
    First Evaluation of the Diagnostic Accuracy of an Automated 3D Ultrasound System in a Breast Screening Setting.
    Anticancer Res. 2011;31:2569-74.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
52. KUNAMI N , Yotsumoto F, Ishitsuka K, Fukami T, et al
    Antitumor effects of CRM197, a specific inhibitor of HB-EGF, in T-cell acute lymphoblastic leukemia.
    Anticancer Res. 2011;31:2483-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
53. NAKAGAWA M , Bando Y, Nagao T, Morimoto M, et al
    Expression of p53, Ki-67, E-Cadherin, N-Cadherin and TOP2A in Triple-negative Breast Cancer.
    Anticancer Res. 2011;31:2389-93.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
54. KIRWAN CC , McDowell G, McCollum CN, Byrne GJ, et al
    Incidence of Venous Thromboembolism during Chemotherapy for Breast Cancer: Impact on Cancer Outcome.
    Anticancer Res. 2011;31:2383-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
55. JIANG L , Ma T, Moran MS, Kong X, et al
    Mammographic features are associated with clinicopathological characteristics in invasive breast cancer.
    Anticancer Res. 2011;31:2327-34.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
56. HOFFMANN O , Heubner M, Anlasik T, Winterhalter M, et al
    Circulating 20S Proteasome in Patients with Non-metastasized Breast Cancer.
    Anticancer Res. 2011;31:2197-201.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
57. SHIPP C , Watson K, Jones GL
    Associations of HSP90 Client Proteins in Human Breast Cancer.
    Anticancer Res. 2011;31:2095-101.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
58. AVGERINOU G , Flessas I, Hatziolou E, Zografos G, et al
    Cutaneous metastasis of signet-ring gastric adenocarcinoma to the breast with unusual clinicopathological features.
    Anticancer Res. 2011;31:2373-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
59. DAHLE J , Kalanxhi E, Tisnek N
    Dosimetry of a 238Pu-based alpha-particle irradiator and its biological application in a study of the bystander effect.
    Anticancer Res. 2011;31:2113-20.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
60. ESKELINEN M , Ollonen P
    Assessment of General Anxiety in Patients with Breast Disease and Breast Cancer Using the Spielberger STAI Self Evaluation Test: A Prospective Case-Control Study in Finland.
    Anticancer Res. 2011;31:1801-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
61. DELPEUCH A , Leveque D, Rob L, Bergerat JP, et al
    Off-label Use of Oxaliplatin in Patients with Metastatic Breast Cancer.
    Anticancer Res. 2011;31:1765-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
62. RAICA M , Cimpean AM, Ceausu R, Ribatti D, et al
    Lymphatic Microvessel Density, VEGF-C, and VEGFR-3 Expression in Different Molecular Types of Breast Cancer.
    Anticancer Res. 2011;31:1757-64.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
63. LI J , Ye L, Mansel RE, Jiang WG, et al
    Potential prognostic value of repulsive guidance molecules in breast cancer.
    Anticancer Res. 2011;31:1703-11.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
64. PRADIER C , Cornuau M, Norca J, Mesbah H, et al
    Differences in breast carcinoma in situ between menopausal and premenopausal women.
    Anticancer Res. 2011;31:1783-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
65. RAJENDRAN S , Collins S, van Pijkeren JP, O'Hanlon D, et al
    Targeting of breast metastases using a viral gene vector with tumour-selective transcription.
    Anticancer Res. 2011;31:1627-35.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
66. WANG X , Yu B, Wu Y, Lee RJ, et al
    Efficient down-regulation of CDK4 by novel lipid nanoparticle-mediated siRNA delivery.
    Anticancer Res. 2011;31:1619-26.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
67. SCHNEGELSBERG B , Schumacher U, Valentiner U
    Lectin Histochemistry of Metastasizing and Non-metastasizing Breast and Colon Cancer Cells.
    Anticancer Res. 2011;31:1589-97.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
68. IWASE S , Yamamoto D, Kuroda Y, Kawaguchi T, et al
    Phase II Trial of Preoperative Chemotherapy for Breast Cancer: Japan Breast Cancer Research Network (JBCRN)-02 Trial.
    Anticancer Res. 2011;31:1483-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
69. LISKA V , Holubec L Jr, Treska V, Vrzalova J, et al
    Evaluation of tumour markers as differential diagnostic tool in patients with suspicion of liver metastases from breast cancer.
    Anticancer Res. 2011;31:1447-51.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
70. STANWAY SJ , Palmieri C, Stanczyk FZ, Folkerd EJ, et al
    Effect of tamoxifen or anastrozole on steroid sulfatase activity and serum androgen concentrations in postmenopausal women with breast cancer.
    Anticancer Res. 2011;31:1367-72.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
71. JIANG M , Ouyang H, Ruan P, Zhao H, et al
    Chitosan derivatives inhibit cell proliferation and induce apoptosis in breast cancer cells.
    Anticancer Res. 2011;31:1321-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
72. FOGELMAN DR , Wolff RA, Kopetz S, Javle M, et al
    Evidence for the efficacy of Iniparib, a PARP-1 inhibitor, in BRCA2-associated pancreatic cancer.
    Anticancer Res. 2011;31:1417-20.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
73. IENI A , Giuffre G, Adamo V, Tuccari G, et al
    Prognostic impact of CD133 immunoexpression in node-negative invasive breast carcinomas.
    Anticancer Res. 2011;31:1315-20.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
74. IBARAGI S , Shimo T, Hassan NM, Isowa S, et al
    Induction of MMP-13 expression in bone-metastasizing cancer cells by type I collagen through integrin alpha1beta1 and alpha2beta1-p38 MAPK signaling.
    Anticancer Res. 2011;31:1307-13.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
75. MILLER CP , Urban N, Blau CA
    Quantitative comparison of erythropoietin receptor levels in the epithelial versus endothelial fractions of primary breast tumors.
    Anticancer Res. 2011;31:1189-95.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
76. JASINSKI P , Zwolak P, Terai K, Vogel RI, et al
    MT477 acts in tumor cells as an AURKA inhibitor and strongly induces NRF-2 signaling.
    Anticancer Res. 2011;31:1181-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
77. GILABERT M , Bertucci F, Esterni B, Madroszyk A, et al
    Capecitabine after Anthracycline and Taxane Exposure in HER2-negative Metastatic Breast Cancer Patients: Response, Survival and Prognostic Factors.
    Anticancer Res. 2011;31:1079-86.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
78. ESKELINEN M , Ollonen P
    Montgomery-Asberg Depression Rating Scale (MADRS) in Healthy Study Subjects, in Patients with Breast Disease and Breast Cancer: A Prospective Case-Control Study.
    Anticancer Res. 2011;31:1065-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
79. DONO M , Ferro P, Franceschini MC, Dessanti P, et al
    Human mammaglobin transcript amplification for differential diagnosis in a breast cancer metastatic to dura mater.
    Anticancer Res. 2011;31:1061-4.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
80. HARTKOPF AD , Wagner P, Wallwiener D, Fehm T, et al
    Changing levels of circulating tumor cells in monitoring chemotherapy response in patients with metastatic breast cancer.
    Anticancer Res. 2011;31:979-84.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
81. ARIAD S , Milk N, Bolotin A, Gopas J, et al
    Measles virus antigens in breast cancer.
    Anticancer Res. 2011;31:913-20.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
82. MALKI A , Bergmeier SC
    Novel quinuclidinone derivative 8a induced apoptosis in human mcf-7 breast cancer cell lines.
    Anticancer Res. 2011;31:871-80.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
83. ZAYTSEVA YY , Wallis NK, Southard RC, Kilgore MW, et al
    The PPAR{gamma} Antagonist T0070907 Suppresses Breast Cancer Cell Proliferation and Motility via Both PPAR{gamma}-dependent and -independent Mechanisms.
    Anticancer Res. 2011;31:813-23.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
84. LO YH , Ho PC, Zhao H, Wang SC, et al
    Inhibition of c-ABL Sensitizes Breast Cancer Cells to the Dual ErbB Receptor Tyrosine Kinase Inhibitor Lapatinib (GW572016).
    Anticancer Res. 2011;31:789-95.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
85. ESKELINEN M , Ollonen P
    Forsen psychological risk inventory for breast cancer patients: a prospective case-control study with special reference to the use of psychiatric medications.
    Anticancer Res. 2011;31:739-44.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
86. LUMACHI F , Norberto L, Zanella S, Marino F, et al
    Axillary node sampling in conjunction with sentinel node biopsy in patients with breast cancer. A prospective preliminary study.
    Anticancer Res. 2011;31:693-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
87. RECCHIA F , Candeloro G, Necozione S, Desideri G, et al
    Premenopausal Hormone-responsive Breast Cancer with Extensive Axillary Nodes Involvement: Total Estrogen Blockade and Chemotherapy.
    Anticancer Res. 2011;31:671-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
88. KHADDAGE A , Berremila SA, Forest F, Clemenson A, et al
    Implementation of Molecular Intra-operative Assessment of Sentinel Lymph Node in Breast Cancer.
    Anticancer Res. 2011;31:585-90.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
89. FORD CH , Al-Bader M, Al-Ayadhi B, Francis I, et al
    Reassessment of estrogen receptor expression in human breast cancer cell lines.
    Anticancer Res. 2011;31:521-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
90. ZHONG S , Ye WP, Feng E, Lin SH, et al
    Serum Derived from Zeranol-implanted ACI Rats Promotes the Growth of Human Breast Cancer Cells In Vitro.
    Anticancer Res. 2011;31:481-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
91. ZHANG H , Slewa A, Janssen E, Skaland I, et al
    The Prognostic Value of the Orphan Nuclear Receptor DAX-1 (NROB1) in Node-negative Breast Cancer.
    Anticancer Res. 2011;31:443-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
92. MANDATO VD , Pirillo D, Gelli MC, Cavina M, et al
    Gastric cancer in a pregnant woman presenting with low back pain and bilateral erythematous breast hypertrophy mimicking primary inflammatory breast carcinoma.
    Anticancer Res. 2011;31:681-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
93. PHILLIPS PG , Yalcin M, Cui H, Abdel-Nabi H, et al
    Increased tumor uptake of chemotherapeutics and improved chemoresponse by novel non-anticoagulant low molecular weight heparin.
    Anticancer Res. 2011;31:411-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
94. YUAN Z , Sanders AJ, Ye L, Wang Y, et al
    Prognostic Value of the Human Antigen R (HuR) in Human Breast Cancer: High Level Predicts a Favourable Prognosis.
    Anticancer Res. 2011;31:303-10.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
95. SHEEN-CHEN SM , Huang CY, Liu YY, Huang CC, et al
    Cortactin in breast cancer: analysis with tissue microarray.
    Anticancer Res. 2011;31:293-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
96. URAMOTO H , Hanagiri T
    Two Cases with a Long-term Survival Following Multidisciplinary Treatment for Recurrent Breast Cancer After Surgery.
    Anticancer Res. 2011;31:277-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
97. TODOROVA VK , Kaufmann Y, Klimberg VS
    Increased efficacy and reduced cardiotoxicity of metronomic treatment with cyclophosphamide in rat breast cancer.
    Anticancer Res. 2011;31:215-20.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
98. GWIN J , Drews N, Ali S, Stamschror J, et al
    Effect of Genistein on p90RSK Phosphorylation and Cell Proliferation in T47D Breast Cancer Cells.
    Anticancer Res. 2011;31:209-14.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
99. BUHMEIDA A , Al-Maghrabi J, Merdad A, Al-Thubaity F, et al
    Prognostic value of mitotic counts in breast cancer of saudi arabian patients.
    Anticancer Res. 2011;31:97-103.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
100. CHONG K , Subramanian A, Sharma A, Mokbel K, et al
     Measuring IGF-1, ER-{alpha} and EGFR Expression Can Predict Tamoxifen-resistance in ER-positive Breast Cancer.
     Anticancer Res. 2011;31:23-32.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
101. ISHITOBI M , Nakahara S, Komoike Y, Motomura K, et al
     Risk of Ipsilateral breast tumor recurrence in patients treated with Tamoxifen or Anastrozole following breast-conserving surgery with or without radiotherapy.
     Anticancer Res. 2011;31:367-71.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
102. TRESKA V , Topolcan O, Vrzalova J, Skalicky T, et al
     Predictive value of serum biomarkers in patients after portal vein embolization (PVE): a pilot study.
     Anticancer Res. 2011;31:339-44.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
103. FADLALLA K , Watson A, Yehualaeshet T, Turner T, et al
     Ruta graveolens extract induces DNA damage pathways and blocks Akt activation to inhibit cancer cell proliferation and survival.
     Anticancer Res. 2011;31:233-41.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
104. GIRAUD S , Loum E, Bessette B, Fermeaux V, et al
     Oncogramme, a new promising method for individualized breast tumour response testing for cancer treatment.
     Anticancer Res. 2011;31:139-45.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
105. LU L , Kanwar J, Schmitt S, Cui QC, et al
     Inhibition of tumor cellular proteasome activity by triptolide extracted from the Chinese medicinal plant 'thunder god vine'.
     Anticancer Res. 2011;31:1-10.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     December 2010
106. SCHALLIER D , Decoster L, Fontaine C, De Greve J, et al
     Pemetrexed-induced eyelid edema: incidence and clinical manifestations.
     Anticancer Res. 2010;30:5185-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
107. ZHONG S , Ye WP, Xu PP, Feng E, et al
     Aromatase expression in leptin-pretreated human breast pre-adipocytes is enhanced by zeranol and suppressed by (-)-gossypol.
     Anticancer Res. 2010;30:5077-84.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
108. FUKAZAWA T , Maeda Y, Matsuoka J, Ono T, et al
     Targeting KRAS Mutation-bearing Lung Cancer In Vivo by Pulmonary Surfactant-Adenovirus-mediated Gene Transfer.
     Anticancer Res. 2010;30:4925-35.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
109. FJELLDAL R , Moe BT, Orbo A, Sager G, et al
     MCF-7 Cell Apoptosis and Cell Cycle Arrest: Non-genomic Effects of Progesterone and Mifepristone (RU-486).
     Anticancer Res. 2010;30:4835-40.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     November 2010
110. BOSE P , Dunn ST, Yang J, Allen R, et al
     c-Kit expression and mutations in phyllodes tumors of the breast.
     Anticancer Res. 2010;30:4731-6.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
111. KATO-NAKANO M , Suzuki M, Kawamoto S, Furuya A, et al
     Characterization and evaluation of the antitumour activity of a dual-targeting monoclonal antibody against claudin-3 and claudin-4.
     Anticancer Res. 2010;30:4555-62.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
112. NOH TW , Soung YH, Kim HI, Gil HJ, et al
     Effect of {beta}4 Integrin Knockdown by RNA Interference in Anaplastic Thyroid Carcinoma.
     Anticancer Res. 2010;30:4485-92.
     PubMed     Text format     Related articles    Abstract available
     
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: